Latest Market Positioning News

Orbital Corporation broadened its international footprint with new UAV propulsion orders across the US, India, and Middle East, while advancing its Power by the Hour service to underpin recurring revenue streams.

SportsHero Limited has broadened its partnership with XLSMART, Indonesia’s third largest telco, to include full marketing support for its HeroPlay mobile gaming platform, targeting a subscriber base of 73 million and kicking off revenue in the September quarter.

Unith Ltd boosted its AI digital human platform with ISO/IEC 27001:2022 certification, launched new SDKs, and secured $2.75 million in fresh capital to fuel growth and commercial expansion.

Fortuna Metals has declared a maiden mineral resource at its Mkanda project in Malawi, ranking it among the top six rutile deposits worldwide, while locking in a strategic US investment of A$8.6 million from WNDR to boost market exposure.

Perpetual Limited recorded solid growth across its divisions in Q4 FY26, with Corporate Trust and Asset Management buoyed by market gains despite net outflows. The company is advancing the sale of its Wealth Management arm to Bain Capital, targeting completion in late 2026.

Clean TeQ Water has commissioned its first full-scale PHOSPHIX® phosphate removal plant in Europe, surpassing regulatory and contractual standards and setting a commercial benchmark for future growth.

Racura Oncology has hit key clinical milestones in its RC220 development, including first patient dosing in a lung cancer trial and dose escalation in a cardioprotection study, supported by a strong $34.3 million cash position.

Tinybeans Group reported a robust Q4 FY26 with total revenue surging 57% to US$1.81 million and adjusted EBITDA more than doubling to US$232,000. The company achieved its third consecutive quarter of operating cash inflows and ended the period with US$1.76 million in cash and zero debt.

Vysarn Limited is set to transform its water services platform with the $60 million acquisition of Welltech, funded by a fully underwritten $65.3 million placement. The deal promises over 37% EPS accretion on a pro forma FY26 basis.

Clinuvel Pharmaceuticals targets year-end for topline results from its pivotal vitiligo trial of SCENESSE® combined with narrowband UVB, aiming to expand the drug's use beyond its current rare disease indication.

Whitehaven Coal delivered a robust finish to FY26, hitting top-end guidance for production and sales while improving safety and reducing costs.

Canadian Phosphate (ASX: CP8) has kicked off a 3,000-metre drilling campaign at its Wapiti Phosphate Project in British Columbia, aiming for a Mineral Resource Estimate by late 2026 that will support both traditional fertilizer and advanced battery material markets.